Prosser S, Arslan E
Audiology Service of the ENT Clinic, University of Ferrara, Italy.
Audiology. 1987;26(3):179-87.
The lesion location (cochlear vs. retrocochlear) of sensorineural hearing loss may be differentiated with a diagnostic index (delta V), which is calculated from the wave V latency of the monaurally evoked auditory brainstem response (ABR), and from the pure-tone hearing threshold at 2 and 4 kHz. The delta V values obtained from 80 recruiting ears have proven to correlate linearly to the amount of the hearing loss, hence allowing to define appropriate confidence boundaries for cochlear hearing losses. In contrast, the delta V values obtained from 32 ears of patients with retrocochlear lesions--cerebellopontine angle (CPA) tumors--were all found to exceed the 95% upper confidence limits projected for cochlear lesions, thus giving a 100% rate of true results in the detection of retrocochlear pathology. These results, providing an ABR parametric model for the cochlear hearing loss, suggest a diagnostic strategy for the early detection of CPA tumors based on the exclusion of a cochlear hearing loss.
感音神经性听力损失的病变位置(耳蜗性与蜗后性)可通过一个诊断指数(δV)来区分,该指数由单耳诱发听觉脑干反应(ABR)的V波潜伏期以及2kHz和4kHz的纯音听力阈值计算得出。从80只重振耳获得的δV值已被证明与听力损失程度呈线性相关,因此能够为耳蜗性听力损失定义适当的置信界限。相比之下,从32例蜗后病变患者(桥小脑角(CPA)肿瘤)的耳朵获得的δV值均超过了针对耳蜗病变预测的95%上置信限,从而在检测蜗后病变时得出了100%的真阳性率。这些结果为耳蜗性听力损失提供了一个ABR参数模型,提示了一种基于排除耳蜗性听力损失来早期检测CPA肿瘤的诊断策略。